D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Materials Science D-index 74 Citations 19,399 210 World Ranking 1402 National Ranking 41

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Cancer
  • Gene

His primary scientific interests are in Nanoparticle, Drug delivery, Nanotechnology, Biophysics and Chitosan. His research in Nanoparticle intersects with topics in Conjugated system, Polymer, Biomedical engineering and Nuclear chemistry. The study incorporates disciplines such as Confocal microscopy, Pharmacology and Ultrasound in addition to Drug delivery.

His Nanotechnology research includes elements of Molecular imaging, Cancer and Multimodal imaging. Kwangmeyung Kim combines subjects such as In vitro, Biochemistry, Hyaluronic acid, Photosensitizer and Photodynamic therapy with his study of Biophysics. His Chitosan research incorporates elements of Surface modification and Microparticle.

His most cited work include:

  • Multifunctional nanoparticles for multimodal imaging and theragnosis (899 citations)
  • Targeted delivery of low molecular drugs using chitosan and its derivatives. (578 citations)
  • Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles (450 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Nanoparticle, Nanotechnology, Biophysics, Drug delivery and Cancer research. His Nanoparticle research is multidisciplinary, incorporating perspectives in Chitosan, Fluorescence, Drug carrier and Biomedical engineering. Kwangmeyung Kim interconnects Molecular imaging, Cancer therapy and Biodistribution in the investigation of issues within Nanotechnology.

His work is dedicated to discovering how Biophysics, Biochemistry are connected with Bioorthogonal chemistry and Click chemistry and other disciplines. The Drug delivery study combines topics in areas such as Liposome, Pharmacology, Tumor targeting and Doxorubicin. His biological study spans a wide range of topics, including Cancer cell, Cancer, Pathology and Cancer immunotherapy.

He most often published in these fields:

  • Nanoparticle (36.22%)
  • Nanotechnology (24.49%)
  • Biophysics (22.19%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (19.64%)
  • Nanoparticle (36.22%)
  • Cancer cell (12.24%)

In recent papers he was focusing on the following fields of study:

Kwangmeyung Kim mainly focuses on Cancer research, Nanoparticle, Cancer cell, Biophysics and Cancer. His work carried out in the field of Cancer research brings together such families of science as Doxorubicin, Immune system, Drug delivery and Cancer immunotherapy. His Nanoparticle research is within the category of Nanotechnology.

His work deals with themes such as Photodynamic therapy and Surface modification, which intersect with Cancer cell. His Biophysics research incorporates themes from Fluorescence, Bioorthogonal chemistry, Azide, Colloidal gold and Iron oxide. Kwangmeyung Kim combines subjects such as Conjugated system, Photoacoustic spectroscopy, Biochemistry and Endocytosis with his study of Cancer.

Between 2017 and 2021, his most popular works were:

  • Engineering nanoparticle strategies for effective cancer immunotherapy. (53 citations)
  • Engineering nanoparticle strategies for effective cancer immunotherapy. (53 citations)
  • Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy (33 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Cancer
  • Gene

The scientist’s investigation covers issues in Cancer research, Cancer cell, Cancer immunotherapy, Peptide and Immunogenic cell death. The concepts of his Cancer research study are interwoven with issues in In vitro, Sudden death, Conjugated system, Cathepsin B and Nanomedicine. His Cancer cell study frequently draws connections between adjacent fields such as Programmed cell death.

His research in Peptide intersects with topics in Cathepsin, Doxorubicin, Prodrug, Toxicity and Cytotoxicity. His Immunogenic cell death study combines topics in areas such as Sonodynamic therapy, Adverse effect, Drug delivery, Necroptosis and Cytotoxic T cell. His Cancer research is multidisciplinary, relying on both Imaging modalities and Tumor targeting.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Multifunctional nanoparticles for multimodal imaging and theragnosis

Dong Eun Lee;Heebeom Koo;In Cheol Sun;Ju Hee Ryu.
Chemical Society Reviews (2012)

1123 Citations

Targeted delivery of low molecular drugs using chitosan and its derivatives.

Jae Hyung Park;Gurusamy Saravanakumar;Kwang Meyung Kim;Ick Chan Kwon.
Advanced Drug Delivery Reviews (2010)

773 Citations

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

Hae Yun Nam;Seok Min Kwon;Seok Min Kwon;Hyunjin Chung;Hyunjin Chung;Seung Young Lee.
Journal of Controlled Release (2009)

561 Citations

Polymeric nanomedicine for cancer therapy

Jae Hyung Park;Seulki Lee;Jong Ho Kim;Kyeongsoon Park.
Progress in Polymer Science (2008)

522 Citations

Self-assembled hyaluronic acid nanoparticles for active tumor targeting.

Ki Young Choi;Hyunjin Chung;Hyunjin Chung;Kyung Hyun Min;Kyung Hyun Min;Hong Yeol Yoon.
Biomaterials (2010)

515 Citations

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.

Kyung Hyun Min;Kyeongsoon Park;Yoo Shin Kim;Sang Mun Bae.
Journal of Controlled Release (2008)

449 Citations

New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy

Kyeongsoon Park;Seulki Lee;Eunah Kang;Kwangmeyung Kim.
Advanced Functional Materials (2009)

430 Citations

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice

Jong Ho Kim;Yoo Shin Kim;Kyeongsoon Park;Seulki Lee.
Journal of Controlled Release (2008)

377 Citations

A Near‐Infrared‐Fluorescence‐Quenched Gold‐Nanoparticle Imaging Probe for In Vivo Drug Screening and Protease Activity Determination

Seulki Lee;Eui Joon Cha;Kyeongsoon Park;Seung Young Lee.
Angewandte Chemie (2008)

375 Citations

In vivo targeted delivery of nanoparticles for theranosis.

Heebeom Koo;Myung Sook Huh;In Cheol Sun;Soon Hong Yuk.
Accounts of Chemical Research (2011)

367 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kwangmeyung Kim

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 107

Ick Chan Kwon

Ick Chan Kwon

Korea Institute of Science and Technology

Publications: 72

Doo Sung Lee

Doo Sung Lee

Sungkyunkwan University

Publications: 71

Jae Hyung Park

Jae Hyung Park

Sungkyunkwan University

Publications: 62

In-San Kim

In-San Kim

Korea Institute of Science and Technology

Publications: 48

Xuesi Chen

Xuesi Chen

Chinese Academy of Sciences

Publications: 47

Kun Na

Kun Na

Catholic University of Korea

Publications: 44

Bin Liu

Bin Liu

National University of Singapore

Publications: 40

Zhuang Liu

Zhuang Liu

Soochow University

Publications: 39

Ben Zhong Tang

Ben Zhong Tang

Chinese University of Hong Kong, Shenzhen

Publications: 37

Zhiyuan Zhong

Zhiyuan Zhong

Soochow University

Publications: 36

Xiangyang Shi

Xiangyang Shi

Donghua University

Publications: 35

Xian-Zheng Zhang

Xian-Zheng Zhang

Wuhan University

Publications: 32

Hao Wang

Hao Wang

University of Southern Queensland

Publications: 32

Yu Seok Youn

Yu Seok Youn

Sungkyunkwan University

Publications: 32

Dan Ding

Dan Ding

Nankai University

Publications: 29

Something went wrong. Please try again later.